Galvani Bioelectronics is a joint venture between GSK and Verily Life Sciences. We are devoted to the development of life changing neuromodulation therapies for patients with chronic disease.
| Website | http://www.galvani.bio |
| Revenue | $6.2 million |
| Employees | 18 (12 on RocketReach) |
| Founded | 2016 |
| Phone | +44 20 8047 5000 |
| Technologies |
JavaScript
,
HTML
,
PHP
+16 more
(view full list)
|
| Industry | Medical Equipment Manufacturing, Medical Devices |
| Web Rank | 11 Million |
| Keywords | Neuromodulation Therapies, Bioelectronic Medicine, Chronic Disease Treatment, Electroceuticals, Peripheral Nerve Stimulation, Medical Device Development, Innovative Treatments, Biotechnology, Precision Medicine, New Therapies, Drug Delivery Systems, Therapeutics, Healthcare Technology, Medical Research, G Protein Coupled Receptors, Nervous System, Clinical Trials, Regenerative Medicine |
| Competitors | Medtronic, Boston Scientific, NeuroPace, Axonics, Inc., Second Sight Medical Products, Synapse Biomedical, Zynex Medical, Inspire Medical Systems, NeuroMetrix, Inc., Palex Cobertura +40 more (view full list) |
Looking for a particular Galvani Bioelectronics employee's phone or email?
Galvani Bioelectronics Questions
The Galvani Bioelectronics annual revenue was $6.2 million in 2026.
Kristoffer Famm is the President and CEO of Galvani Bioelectronics.
12 people are employed at Galvani Bioelectronics.
Top Galvani Bioelectronics Employees
-
12
-
Raolat Abdulai
Chief Medical Officer at Galvani Bioelectronics
Washington, DC, US
Related Companies
G2Crowd Trusted
300K+
Plugin Users
